nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Henoch-Schonlein purpura—Hydrochlorothiazide—nephrolithiasis	0.0739	0.0804	CcSEcCtD
Carbidopa—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0623	0.0678	CcSEcCtD
Carbidopa—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0363	0.0395	CcSEcCtD
Carbidopa—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0273	0.0297	CcSEcCtD
Carbidopa—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0265	CcSEcCtD
Carbidopa—DDC—nephron tubule—nephrolithiasis	0.0224	0.274	CbGeAlD
Carbidopa—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0214	0.0233	CcSEcCtD
Carbidopa—DDC—renal system—nephrolithiasis	0.0204	0.249	CbGeAlD
Carbidopa—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0202	0.022	CcSEcCtD
Carbidopa—DDC—kidney—nephrolithiasis	0.0197	0.241	CbGeAlD
Carbidopa—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0194	0.0211	CcSEcCtD
Carbidopa—DDC—cortex of kidney—nephrolithiasis	0.0192	0.235	CbGeAlD
Carbidopa—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.017	0.0185	CcSEcCtD
Carbidopa—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0172	CcSEcCtD
Carbidopa—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0153	CcSEcCtD
Carbidopa—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0148	CcSEcCtD
Carbidopa—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0147	CcSEcCtD
Carbidopa—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.013	0.0142	CcSEcCtD
Carbidopa—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0129	0.014	CcSEcCtD
Carbidopa—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0138	CcSEcCtD
Carbidopa—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0133	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0133	CcSEcCtD
Carbidopa—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0133	CcSEcCtD
Carbidopa—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0131	CcSEcCtD
Carbidopa—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0125	CcSEcCtD
Carbidopa—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0124	CcSEcCtD
Carbidopa—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0121	CcSEcCtD
Carbidopa—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.011	0.0119	CcSEcCtD
Carbidopa—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0117	CcSEcCtD
Carbidopa—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0115	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00978	0.0106	CcSEcCtD
Carbidopa—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00972	0.0106	CcSEcCtD
Carbidopa—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00957	0.0104	CcSEcCtD
Carbidopa—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0101	CcSEcCtD
Carbidopa—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00919	0.01	CcSEcCtD
Carbidopa—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00919	0.01	CcSEcCtD
Carbidopa—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00912	0.00993	CcSEcCtD
Carbidopa—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00875	0.00953	CcSEcCtD
Carbidopa—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00844	0.00919	CcSEcCtD
Carbidopa—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00912	CcSEcCtD
Carbidopa—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00781	0.00851	CcSEcCtD
Carbidopa—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0081	CcSEcCtD
Carbidopa—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00786	CcSEcCtD
Carbidopa—Tension—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00783	CcSEcCtD
Carbidopa—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00782	CcSEcCtD
Carbidopa—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00712	0.00775	CcSEcCtD
Carbidopa—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00709	0.00772	CcSEcCtD
Carbidopa—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00705	0.00767	CcSEcCtD
Carbidopa—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00691	0.00752	CcSEcCtD
Carbidopa—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00687	0.00748	CcSEcCtD
Carbidopa—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0068	0.00741	CcSEcCtD
Carbidopa—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00677	0.00738	CcSEcCtD
Carbidopa—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00733	CcSEcCtD
Carbidopa—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0067	0.00729	CcSEcCtD
Carbidopa—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00661	0.0072	CcSEcCtD
Carbidopa—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00657	0.00716	CcSEcCtD
Carbidopa—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00714	CcSEcCtD
Carbidopa—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00648	0.00705	CcSEcCtD
Carbidopa—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00701	CcSEcCtD
Carbidopa—Cough—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00696	CcSEcCtD
Carbidopa—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00679	CcSEcCtD
Carbidopa—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00677	CcSEcCtD
Carbidopa—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00671	CcSEcCtD
Carbidopa—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00665	CcSEcCtD
Carbidopa—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00657	CcSEcCtD
Carbidopa—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00651	CcSEcCtD
Carbidopa—Shock—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00641	CcSEcCtD
Carbidopa—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00586	0.00638	CcSEcCtD
Carbidopa—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00578	0.0063	CcSEcCtD
Carbidopa—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00621	CcSEcCtD
Carbidopa—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00609	CcSEcCtD
Carbidopa—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00589	CcSEcCtD
Carbidopa—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00585	CcSEcCtD
Carbidopa—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00581	CcSEcCtD
Carbidopa—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00579	CcSEcCtD
Carbidopa—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00573	CcSEcCtD
Carbidopa—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00566	CcSEcCtD
Carbidopa—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00562	CcSEcCtD
Carbidopa—Pain—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00557	CcSEcCtD
Carbidopa—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00557	CcSEcCtD
Carbidopa—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00537	CcSEcCtD
Carbidopa—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00533	CcSEcCtD
Carbidopa—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00517	CcSEcCtD
Carbidopa—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00515	CcSEcCtD
Carbidopa—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00515	CcSEcCtD
Carbidopa—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0048	CcSEcCtD
Carbidopa—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00467	CcSEcCtD
Carbidopa—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00461	CcSEcCtD
Carbidopa—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00446	CcSEcCtD
Carbidopa—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00431	CcSEcCtD
Carbidopa—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00414	CcSEcCtD
Carbidopa—Rash—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00411	CcSEcCtD
Carbidopa—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00377	0.0041	CcSEcCtD
Carbidopa—Headache—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00408	CcSEcCtD
Carbidopa—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00387	CcSEcCtD
